Clinical Trials Browser

OTHER × Lead × Thoracic × Clear all

NCT01967095 2018-11-13

Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer

Phase 1 Completed

EGFR-Mutant Lung Cancer

NCT01797471 2017-12-21

Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer

Phase NA Terminated

1 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms